marijuana stocks news

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) producing 1,000,000 cans as it ramps up production to meet current demand

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that it is currently working with Ball Corporation (“Ball”) (BLL) to produce 1,000,000 printed KOIOS cans as production levels ramp up to meet current demands.

Ball supplies innovative, sustainable packaging solutions for beverage, personal care, and household products customers, as well as aerospace and other technologies and services primarily for the U.S. government. Ball and its subsidiaries employ more than 17,500 people worldwide and reported 2018 net sales of $11.6 billion 1.

“We have been working with Ball for many years and they are tremendous partners. By printing our cans in this large of a quantity it will allow us to meet current demands, and it decreases our costs which further allows us to increase our margins substantially,” said Chris Miller CEO of Koios. Adding further, “This cost savings allows us to pass on an added benefit to the consumer. Securing the cans now was a crucial step to put us in the correct position to meet our sales forecasts during the next quarter”.

Earlier this year Koios signed retail agreements with two of the largest retailers in the world which added over 5,000 additional retail locations across the US that now carry the Koios beverage line.

See those announcements here: KOIOS Major Retailer Agreement and KOIOS Major Retailer Agreement.

Ball takes pride in creating packaging that is smart, practical, sustainable and eye-catching. This philosophy falls right in line with how Koios aims to present its beverage line to the consumer.  Mass production aligned with intelligent packaging will ensure that the Company’s quality products will be distributed to the consumer while maintaining the integrity of the KOIOS brand.

On behalf of the Board of Directors of the Company.


“Chris Miller”

Chris Miller , CEO, and Director

About Koios Beverage Corp.

The Company is an emerging functional beverage company which has an available distribution network of more than 5,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States , including GNC, Walmart Inc., and Wishing-U-Well.  Together these retailers represent over 50,000 brick and mortar locations across the United States from sports nutrition stores to large natural grocery chains. Through its partnership with Wishing-U-Well, Koios also enjoys a large presence online, including being an Amazon choice product.

Koios is also the sole owner of Cannavated Beverage Corp., a subsidiary that develops beverage products and formulas for the growing CBD market. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants.  Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity.  Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.

Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website:

Forward-Looking Statements

This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding: statements with respect to the growth and size of the functional beverage and CBD infused beverage markets; statements with respect to our projected sales forecasts and production demands; statements with respect to our relationship with Ball Corporation; statements with respect to the perceived benefits of mass production of the Company’s cans; and statements regarding the business of the Company. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the functional and CBD infused beverage markets; (iii) consumer acceptance and adoption of functional beverages and CBD infused beverages as compared to other beverages; (v) changes which may affect the legalization of markets in the US and Canada ; and (v) other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

Koios has not conducted any scientific studies on the effects of Koios’ products which have been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking Koios’ products will vary from person to person. No claims or guarantees can be made as to the effects of Koios’ products on an individual’s health and wellbeing.

SOURCE Koios Beverage Corp.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

mCig, Inc. (MCIG) Subsidiary BRRX Clinical Announces Launch of New Website

mCig, Inc. Subsidiary BRRX Clinical Announces Launch of New Website, on Monday,…

Canopy Growth Corporation (WEED.TO) (CGC) Acquires Storz & Bickel

Canopy Growth Acquires Storz & Bickel Canopy Growth Corporation (WEED.TO) (CGC) (the…

AbbVie Inc. (ABBV) to Present at the Morgan Stanley Healthcare Conference

AbbVie to Present at the Morgan Stanley Healthcare Conference AbbVie (NYSE: ABBV)…

Curaleaf Holdings, Inc. (CURLF) Expands Retail Presence in Florida with Grand Opening of Spring Hill Dispensary

Curaleaf Expands Retail Presence in Florida with Grand Opening of Spring Hill…